Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics

Published:2021 Issue: Volume: Page:175-200
ISSN:2523-8027
Container-title:Nanotechnology in the Life Sciences
language:
Short-container-title:

Author:

Pindiprolu Sai Kiran S. S.,Krishnamurthy Praveen Thaggikuppe,Chintamaneni Pavan Kumar,Ammu V. V. V. Ravi Kiran,Garikapati Kusuma Kumari

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-76263-6_7

Reference106 articles.

1. Abeylath, S. C., Ganta, S., Iyer, A. K., & Amiji, M. (2011). Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery. Accounts of Chemical Research, 44(10), 1009–1017.

2. Al-Jamal, W. T., & Kostarelos, K. (2011). Liposomes: From a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Accounts of Chemical Research, 44(10), 1094–1104.

3. Allen, T. M. (1994). Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends in Pharmacological Sciences, 15(7), 215–220.

4. Amreddy, N., Babu, A., Panneerselvam, J., Srivastava, A., Muralidharan, R., Chen, A., et al. (2018). Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine: Nanotechnology, Biology and Medicine, 14(2), 373–384.

5. Arleth, L., Ashok, B., Onyuksel, H., Thiyagarajan, P., Jacob, J., & Hjelm, R. P. (2005). Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media. Langmuir, 21(8), 3279–3290.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia;Cancer Letters;2024-04

2. Targeting triple negative breast cancer stem cells using nanocarriers;Discover Nano;2024-03-07

3. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer;Journal of Drug Delivery Science and Technology;2023-09

4. Amelioration of the therapeutic potential of gefitinib against breast cancer using nanostructured lipid carriers;Nanomedicine;2023-08

5. Engineered upconversion nanocarriers for synergistic breast cancer imaging and therapy: Current state of art;Journal of Controlled Release;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3